Cardinal Health Stock News

Equities research analysts expect that Cardinal Health, Inc. (NYSE:CAH) will announce earnings of $1.49 per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Cardinal Healths earnings, with the lowest EPS estimate coming in at $1.31 and the highest estimate coming in at $1.73. Cardinal Health posted []

DUBLIN--(BUSINESS WIRE)--The "U.S. Hospital Gowns Market Size, Share & Trends Analysis Report By Type (Surgical Gowns, Non-surgical Gowns, Patient Gowns), By Usability (Disposable Gowns, Reusable Gowns), By Risk Type, And Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com''s offering. The U.S. hospital gowns market size is expected to reach USD 2.47 billion by 2028, expanding at a CAGR of 11.90%. The rising incidence of Hospital Acquired Infections (HAIs), impact

Cardinal Health: This 4% Yielding Dividend Aristocrat Could Triple In The Next 5 Years

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain

Overview of Global Negative Pressure Wound Therapy Devices Market: Because every market research report is unique and deserves a judicious treatment, adept and skilled team works hard to craft an imperative Negative Pressure Wound Therapy Devices Market research report. Quality standards

Greylin Investment Mangement Inc. raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 218.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 105,368 shares of the companys stock after buying an additional 72,253 shares during the period. Cardinal []

IFG Advisory LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 19.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,270 shares of the company’s stock after selling 1,037 shares during the quarter. IFG Advisory LLC’s holdings in Cardinal Health were […]

Level Four Advisory Services LLC decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 0.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 37,907 shares of the companys stock after selling 223 shares during the quarter. Level Four Advisory Services []

LAKE COUNTY, Calif. The Lakeport City Council this week voted to take action on two cases of litigation as part of seeking settlements for the impact of the opioid crisis on the city and its residents. Following the open session of its regular Tuesday night meeting, the council went into a nearly hourlong closed session just before 6:45 p.m. to discuss the citys lawsuit against opioid distributor AmerisourceBergen Drug Corp. as well as another potential case of litigation. When the council emerged shortly after 7:35 p.m., City Attorney David Ruderman said the council had voted 5-0 to approve a settlement with McKesson, AmerisourceBergen, Cardinal Health and Janssen, also known as Johnson & Johnson, regarding the citys lawsuit against them related to their contribution to the opioid epidemic. The city reported that the settlement will provide up to $2.263 billion to California and its 431 eligible counties and cities. On July 21, several states attorneys general, including Californias, entered into a $26 billion settlement with Cardinal, McKesson and AmerisourceBergen the nations three major pharmaceutical distributors and Johnson & Johnson, which manufactured and marketed opioids.

Cardinal Health's (CAH) business introduces new offering for clinical labs that can enable them to focus on patient care.

Las Vegas, USA, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Urinary Catheters Market is Anticipated to Grow at a Tremendous CAGR of 6.63% and is Expected to Expand to USD 4.55 Billion by 2026, Asserts DelveInsight As per DelveInsight Analysis for Urinary Catheters market, the escalating prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and urinary strictures, among others, and growing surgical procedures worldwide are some of the key factors, which are anticipated to increase the overall demand of Urinary Catheters, thereby augmenting the growth of Urinary Catheters market. DelveInsight''s Urinary Catheters Market Insights and Forecast report provides the current and forecast Urinary Catheters, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Urinary Catheters. Some of the essential takeaways from the Urinary Catheters Market report: As per an analysis by DelveInsight, North America is expected to dominate the overall Urinary Catheters Market during the forecast period.

The city of Vicksburg could receive more than $200,000 pending the resolution of a settlement with a group of opioid manufacturers. According to a Nov. 1 letter from the Attorney Generals office, Mississippi as a whole stands to get $200 million under the terms of the proposed settlement with manufacturers Cardinal Health, McKesson, AmerisourceBergen and [] The post Vicksburg could get $200,000-plus from opioid suit settlement appeared first on The Vicksburg Post .

DUBLIN--(BUSINESS WIRE)--The "Non-Durable Goods Merchant Wholesalers Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com''s offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global non-durable goods merchant wholesalers market as it emerges from the COVID -19 shut down. The global non-durable goods merchant wholesalers market reached a

Cardinal Health (NYSE:CAH) had its price objective cut by Credit Suisse Group from $53.00 to $50.00 in a research report sent to investors on Monday morning, Price Targets.com reports. They currently have a neutral rating on the stock. Several other analysts have also recently issued reports on CAH. TheStreet raised shares of Cardinal Health from []